Drug Accountability And Destruction Reporting

Closing The Clinical Supply Chain Information Loop

Lack of accurate accountability logs at the end of a clinical study can trigger warning letters from regulators, delaying or even eliminating acceptance of trial data from a non-conforming site.This in turn can delay trial completion and subsequent product approvals, which carries significant costs in terms of lost opportunities…

Read more about this here

When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?

Your bridge between life-changing therapies and patients